Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12-month price […]
Commonwealth of Pennsylvania Public School Empls Retrmt SYS lessened its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 48,581 shares of the company’s stock after selling 523 shares during the period. Commonwealth of […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) COO Daryl Gaugler sold 1,047 shares of the business’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $37.87, for a total transaction of $39,649.89. Following the completion of the transaction, the chief operating officer now owns 21,539 shares in […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) COO Daryl Gaugler sold 1,047 shares of the stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $37.87, for a total value of $39,649.89. Following the completion of the transaction, the chief operating officer now owns 21,539 shares […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) COO Daryl Gaugler sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $38.74, for a total transaction of $38,740.00. Following the transaction, the chief operating officer now owns 23,591 shares in the […]